Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue (Q42820080)

8 November 2017

Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue (English)

1 reference

8 November 2017

Galina Apostolova

1

1 reference

8 November 2017

Roberto A S Schweizer

2

1 reference

8 November 2017

Zoltan Balazs

3

1 reference

8 November 2017

Radina M Kostadinova

4

1 reference

8 November 2017

Alex Odermatt

5

1 reference

8 November 2017

language of work or name

1 reference

21 December 2004

1 reference

American Journal of Physiology - Endocrinology and Metabolism

8 November 2017

1 reference

8 November 2017

288

1 reference

8 November 2017

E957-64

1 reference

8 November 2017

5

1 reference

Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice

8 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Cooperativity between 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the lumen of the endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta -hydroxysteroid dehydrogenase type 1 expression and activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Dehydroepiandrosterone affects the expression of multiple genes in rat liver including 11 beta-hydroxysteroid dehydrogenase type 1: a cDNA array analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Studies on neurosteroids XIV. Levels of dehydroepiandrosterone sulfate in rat brain and serum determined with newly developed enzyme-linked immunosorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Rapid inhibition of leptin signaling by glucocorticoids in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Suppression of DHEA sulfotransferase (Sult2A1) during the acute-phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Participation of Endogenous Dehydroepiandrosterone and Its Sulfate in the Pathology of Collagen-Induced Arthritis in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Dehydroepiandrosterone up-regulates resistin gene expression in white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Obesity as a medical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

PPAR-gamma activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Subcutaneous adipose 11 beta-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

A transgenic model of visceral obesity and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Altered levels of hypothalamic-pituitary-adrenocortical axis hormones in baboons and mice during the course of infection with Schistosoma mansoni

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

11Beta-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Differential effects of the NADPH/NADP+ ratio on the activities of hexose-6-phosphate dehydrogenase and glucose-6-phosphate dehydrogenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Ciliary neurotrophic factor influences endocrine adipocyte function: inhibition of leptin via PI 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Metabolic syndrome without obesity: Hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Dehydroepiandrosterone stimulates glucose uptake in human and murine adipocytes by inducing GLUT1 and GLUT4 translocation to the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma ) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Pathophysiology of modulation of local glucocorticoid levels by 11beta-hydroxysteroid dehydrogenases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

11Beta-hydroxysteroid dehydrogenase inhibition improves cognitive function in healthy elderly men and type 2 diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Dehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

A rapid screening assay for inhibitors of 11beta-hydroxysteroid dehydrogenases (11beta-HSD): flavanone selectively inhibits 11beta-HSD1 reductase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Liver X receptors downregulate 11beta-hydroxysteroid dehydrogenase type 1 expression and activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Reduced testosterone and adrenal C19 steroid levels in obese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Increased serum leptin protects from adiposity despite the increased glucose uptake in white adipose tissue in mice lacking p85alpha phosphoinositide 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Effect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

C/EBP regulates hepatic transcription of 11beta -hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

Gender difference in the leptin response to feeding in peroxisome-proliferator-activated receptor-alpha knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00442.2004

10.1152/AJPENDO.00442.2004

21 January 2018

Identifiers

DOI

1 reference

8 November 2017

1 reference